Operating Income (Loss) of Bionik Laboratories Corp. from 31 Dec 2010 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bionik Laboratories Corp. quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Dec 2010 to 31 Mar 2023.
  • Bionik Laboratories Corp. Operating Income (Loss) for the quarter ending 31 Mar 2023 was $1,297,123, a 7.4% increase year-over-year.
  • Bionik Laboratories Corp. Operating Income (Loss) for the twelve months ending 31 Mar 2023 was $4,825,039, a 52% increase year-over-year.
  • Bionik Laboratories Corp. annual Operating Income (Loss) for 2022 was $4,825,039, a 52% increase from 2021.
  • Bionik Laboratories Corp. annual Operating Income (Loss) for 2021 was $9,973,199, a 25% increase from 2020.
  • Bionik Laboratories Corp. annual Operating Income (Loss) for 2020 was $13,337,325, a 47% increase from 2019.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Bionik Laboratories Corp. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $4,825,039 $1,297,123 +$104,174 +7.4% 01 Jan 2023 31 Mar 2023 10-K 21 Jun 2023 2023 FY
Q4 2022 $4,929,213 $1,043,404 +$5,685,031 +84% 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2023 2023 Q3
Q3 2022 $10,614,244 $1,111,212 -$69,630 -6.7% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2022 2023 Q2
Q2 2022 $10,544,614 $1,373,300 -$571,415 -71% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2022 2022 Q1
Q1 2022 $9,973,199 $1,401,297 -$434,547 -45% 01 Jan 2022 31 Mar 2022 10-K 21 Jun 2023 2023 FY
Q4 2021 $9,538,652 $6,728,435 +$2,140,197 +24% 01 Oct 2021 31 Dec 2021 10-Q 08 Feb 2023 2023 Q3
Q3 2021 $11,678,849 $1,041,582 +$501,825 +33% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2023 Q2
Q2 2021 $12,180,674 $801,885 +$1,156,651 +59% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q1
Q1 2021 $13,337,325 $966,750 01 Jan 2021 31 Mar 2021 10-K 09 Jun 2022 2022 FY
Q4 2020 $8,868,632 -$5,740,180 -183% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022 2022 Q3
Q3 2020 $1,543,407 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2022 Q2
Q2 2020 $1,958,536 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2022 Q1
Q4 2019 $3,128,452 01 Oct 2019 31 Dec 2019 10-Q 11 Feb 2021 2020 Q3
Q3 2015 $1,177,312 -$4,057 -0.35% 01 Jul 2015 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 $2,418,910 -$1,791,337 -285% 01 Apr 2015 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 $1,246,673 -$1,164,192 -1411% 01 Jan 2015 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q3 2014 $1,173,255 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $627,573 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 $82,481 01 Jan 2014 31 Mar 2014 10-Q 20 May 2015 2015 Q1

Bionik Laboratories Corp. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $4,825,039 +$5,148,160 +52% 01 Apr 2022 31 Mar 2023 10-K 21 Jun 2023 2023 FY
2021 $9,973,199 +$3,364,126 +25% 01 Apr 2021 31 Mar 2022 10-K 21 Jun 2023 2023 FY
2020 $13,337,325 +$11,749,617 +47% 01 Apr 2020 31 Mar 2021 10-K 09 Jun 2022 2022 FY
2019 $25,086,942 01 Apr 2019 31 Mar 2020 10-K 24 Jun 2021 2021 FY
2013 $1,451,769 -$514,710 -55% 01 Apr 2013 31 Mar 2014 10-KT 27 May 2015 2014 FY
2012 $937,059 -$932,580 -20821% 01 Apr 2012 31 Mar 2013 10-KT 27 May 2015 2014 FY
2011 $4,479 +$3,587 +44% 01 Jan 2011 31 Dec 2011 10-K 11 Apr 2012 2011 FY
2010 $8,066 08 Jan 2010 31 Dec 2010 10-K 11 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.